PAA

2.63%

19.5¢ pharmaust limited

PharmAust MPL - Effectiveness against Cancer and COVID-19., page-87

First 87 Last

Share
Profile

Follow
futureup

214 Posts.

92

22/08/20

19:20

Post #: 46741640
Share

Originally posted by Davidsmith80: ↑

Found this in the link above:

PharmAusthas already patented Monepantel, or MPL as it is often termed, in significant global territories including the US, Australia and China as the Perth-based company moves to shore up its IP protection worldwide.
However, unlike several previous patents, this week’s announcement covers non-cancer applications of the drug and in particular its potential ability to treat neurodegenerative conditions, diabetes and illnesses linked to ageing.
The latest patent grant means thatPharmAust’s non-cancer patents have now been granted in the US and Europe.
PharmAustCEO DrRichard Hopkinssaid:“In addition to granted patents covering the use of AADs to treat cancer,PharmAusthas secured a methods patent covering the use of these compounds of non-cancer indications such as neurodegenerative diseases, diabetes and age-related disorders.”
The patent will see the company explore the body’s mTOR pathway – a key point where disease is regulated – and determine how it can be targeted by MPL to help combat a range of non-cancer diseases, the company said.
The announcement comes after the Pharmaust was recently granted a patent in Europe to use AADs as potent kinase inhibitors for the treatment of cancer.
The clinical-stage oncology firm also recently inked a deal with leading Japanese pharma, Nihon Nohyaku Co Ltd, givingPharmAustrights to over 50 promising anti-cancer patents.
Pharmaust is currently in the late stages of reformulating MPL to improve its taste and increase the dosage capacity of the drug which has performed well in recent human and canine clinical trials.

Expand

Theres going to be some mind blowing ANN'S coming up that will make us all forget about the update drought thats for sure!

PAA Price at posting: 23.0¢ Sentiment: Buy Disclosure: Held
19 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 1 more message in this thread...

First 87 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 19.5¢		Change 0.005(2.63%)		Mkt cap ! $94.89M

Open	High	Low	Value	Volume
19.0¢	19.5¢	19.0¢	$58.40K	305.6K

Buyers (Bids)

No.	Vol.	Price($)
2	115000	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
19.5¢	86074	3

View Market Depth

No.	Vol.	Price($)
1	100000	0.190
8	156232	0.185
10	635662	0.180
10	482365	0.175
8	151233	0.170

Price($)	Vol.	No.
0.195	86074	3
0.200	256824	3
0.205	113150	5
0.210	333355	8
0.215	266995	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PAA (ASX) Chart

PharmAust MPL - Effectiveness against Cancer and COVID-19., page-87

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PharmAust MPL - Effectiveness against Cancer and COVID-19., page-87

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News